Tinasas, Cyford .

HRN: 29-23-65  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
07/03/2026
07/10/2026
PO
5ML
Q8HRS
AMOEBIASIS
Remove - Pending Acceptance
07/03/2026
CEFTRIAXONE 1G (VIAL)
07/03/2026
07/09/2026
IV
780mg
OD
Severe Infection W/ Cholestatic Hepatitis
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: